The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Paraneoplastic Cerebellar Degeneration

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Paraneoplastic Cerebellar Degeneration

 

High impact information on Paraneoplastic Cerebellar Degeneration

 

Chemical compound and disease context of Paraneoplastic Cerebellar Degeneration

 

Anatomical context of Paraneoplastic Cerebellar Degeneration

 

Gene context of Paraneoplastic Cerebellar Degeneration

 

Analytical, diagnostic and therapeutic context of Paraneoplastic Cerebellar Degeneration

References

  1. The MAZ protein is an autoantigen of Hodgkin's disease and paraneoplastic cerebellar dysfunction. Bataller, L., Wade, D.F., Graus, F., Rosenfeld, M.R., Dalmau, J. Ann. Neurol. (2003) [Pubmed]
  2. Association of anti-Yo (type I) antibody with paraneoplastic cerebellar degeneration in the setting of transitional cell carcinoma of the bladder: detection of Yo antigen in tumor tissue and fall in antibody titers following tumor removal. Greenlee, J.E., Dalmau, J., Lyons, T., Clawson, S., Smith, R.H., Pirch, H.R. Ann. Neurol. (1999) [Pubmed]
  3. A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration. Anderson, N.E., Budde-Steffen, C., Wiley, R.G., Thurman, L., Rosenblum, M.K., Nadeau, S.E., Posner, J.B. Neurology (1988) [Pubmed]
  4. Proteasome antibodies in paraneoplastic cerebellar degeneration. Storstein, A., Knudsen, A., Vedeler, C.A. J. Neuroimmunol. (2005) [Pubmed]
  5. Heterogeneous expression of CD59 on human Purkinje cells. Storstein, A., Knudsen, A., Bjørge, L., Meri, S., Vedeler, C. Neurosci. Lett. (2004) [Pubmed]
  6. The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival. Okano, H.J., Park, W.Y., Corradi, J.P., Darnell, R.B. Genes Dev. (1999) [Pubmed]
  7. Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Fathallah-Shaykh, H., Wolf, S., Wong, E., Posner, J.B., Furneaux, H.M. Proc. Natl. Acad. Sci. U.S.A. (1991) [Pubmed]
  8. Cerebellar degeneration-related antigen: a highly conserved neuroectodermal marker mapped to chromosomes X in human and mouse. Chen, Y.T., Rettig, W.J., Yenamandra, A.K., Kozak, C.A., Chaganti, R.S., Posner, J.B., Old, L.J. Proc. Natl. Acad. Sci. U.S.A. (1990) [Pubmed]
  9. Characterization of a cDNA encoding a 34-kDa Purkinje neuron protein recognized by sera from patients with paraneoplastic cerebellar degeneration. Furneaux, H.M., Dropcho, E.J., Barbut, D., Chen, Y.T., Rosenblum, M.K., Old, L.J., Posner, J.B. Proc. Natl. Acad. Sci. U.S.A. (1989) [Pubmed]
  10. Carbonic anhydrase-related protein VIII: autoantigen in paraneoplastic cerebellar degeneration. Bataller, L., Sabater, L., Saiz, A., Serra, C., Claramonte, B., Graus, F. Ann. Neurol. (2004) [Pubmed]
  11. Absence of antibodies to non-NMDA glutamate-receptor subunits in paraneoplastic cerebellar degeneration. Degenhardt, A., Duvoisin, R.M., Frennier, J., Gultekin, S.H., Rosenfeld, M.R., Posner, J.B., Dalmau, J. Neurology (1998) [Pubmed]
  12. Immunological and clinical response to immunosuppressive treatment in paraneoplastic cerebellar degeneration. Stark, E., Wurster, U., Patzold, U., Sailer, M., Haas, J. Arch. Neurol. (1995) [Pubmed]
  13. Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody. Tanaka, M., Tanaka, K., Tokiguchi, S., Shinozawa, K., Tsuji, S. J. Neurol. Sci. (1999) [Pubmed]
  14. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice. Tanaka, K., Tanaka, M., Igarashi, S., Onodera, O., Miyatake, T., Tsuji, S. Clinical neurology and neurosurgery. (1995) [Pubmed]
  15. Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionpathy. Budde-Steffen, C., Anderson, N.E., Rosenblum, M.K., Posner, J.B. Cancer Res. (1988) [Pubmed]
  16. Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Furneaux, H.F., Reich, L., Posner, J.B. Neurology (1990) [Pubmed]
  17. HLA A24 in paraneoplastic cerebellar degeneration with anti-Yo antibody. Tanaka, M., Tanaka, K. Neurology (1996) [Pubmed]
  18. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease. Graus, F., Dalmau, J., Valldeoriola, F., Ferrer, I., Reñe, R., Marin, C., Vecht, C.J., Arbizu, T., Targa, C., Moll, J.W. J. Neuroimmunol. (1997) [Pubmed]
  19. Cytotoxic T cell activity against the peptide, AYRARALEL, from Yo protein of patients with the HLA A24 or B27 supertype and paraneoplastic cerebellar degeneration. Tanaka, M., Tanaka, K., Tsuji, S., Kawata, A., Kojima, S., Kurokawa, T., Kira, J., Takiguchi, M. J. Neurol. Sci. (2001) [Pubmed]
  20. Immunofluorescent labeling of nonhuman cerebellar tissue with sera from patients with systemic cancer and paraneoplastic cerebellar degeneration. Greenlee, J.E., Sun, M. Acta Neuropathol. (1985) [Pubmed]
  21. Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration. Tanaka, K., Tanaka, M., Onodera, O., Igarashi, S., Miyatake, T., Tsuji, S. J. Neurol. Sci. (1994) [Pubmed]
  22. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss. Tanaka, M., Tanaka, K., Onodera, O., Tsuji, S. Clinical neurology and neurosurgery. (1995) [Pubmed]
  23. Autoimmune paraneoplastic cerebellar degeneration: immunohistological localization of antibody-binding sites. Nardelli, E., Currò-Dossi, B., Rizzuto, N., Graus, F. Clinical neurology and neurosurgery. (1995) [Pubmed]
 
WikiGenes - Universities